Inari
Cambridge, US · Founded 2016 · Delaware corporation · 494 employees on LinkedIn · 11 known investors
Inari applies artificial intelligence and gene editing to accelerate plant breeding, delivering crop improvement solutions for farmers focused on soybeans, corn, and wheat across broadacre agriculture.
Founders & leadership
LS
Lisa SafarianCEO
SB
Stuart BrownChief Financial Officer
PB
Pierre-Etienne BoinSecretary and General Counsel
PT
Ponsi TrivisvavetPresident and Chief Executive Officer
Board
RB
Robert Berendes, Ph.D.Board director
IM
Ignacio Martinezin𝕏Co-Founder, Chairman, Founding President and CEOGeneral Partner at Flagship Pioneering
RR
Robert RosielloBoard director
SV
Sophie V. VandebroekBoard director
MM
Michael MackChairman of the Board
RI
Robert I. BechekBoard director
HB
Howard BuffettBoard director
Investors · 11
Flagship Pioneering✓ verifiedCambridge · $500K – $10M
Acre Venture PartnersSanta Monica · $100K – $10M
Congruent VenturesSan Francisco · $100K – $5M
G SquaredChicago
Also in the syndicate · 7
Canada Pension Plan Investment Board (CPP Investments)Hanwha ImpactNGS SuperRCM Private Markets fundRivas CapitalRokos Capital Management (US) LPState of Michigan Retirement System
Reported raises · per SEC filings
Form D private placements$335M disclosed across 3 of 5 rounds · 2018–2025
▶$207.6MraisedMay 2021 · 24 investors · AgricultureRule 506(b)
▶$207.6MraisedMay 2021 · 24 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Robert Berendes, Ph.D.Director
- Robert RosielloDirector
- Sophie V. VandebroekDirector
- Michael MackDirector
- Ignacio MartinezDirector
- Stuart BrownExecutive Officer
- Robert I. BechekDirector
- Pierre-Etienne BoinExecutive Officer
- Ponsi TrivisvavetExecutive Officer, Director
- Howard W. BuffettDirector
- Offering amount
- $207.6M
- Amount sold
- $207.6M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$87.3MraisedJul 2019 · 18 investors · AgricultureRule 506(b)
▶$87.3MraisedJul 2019 · 18 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Ponsi TrivisvavetExecutive Officer, Director
- Howard BuffettDirector
- James Tom Halverson, Jr.Executive Officer
- Robert Berendes, Ph.D.Director
- William W. Helman IVDirector
- Michael MackDirector
- Robert RosielloDirector
- Ignacio MartinezExecutive Officer, Director
- Offering amount
- $87.3M
- Amount sold
- $87.3M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$40.1MraisedAug 2018 · 10 investors · AgricultureRule 506(b)
▶$40.1MraisedAug 2018 · 10 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Michael MackDirector
- Ignacio MartinezExecutive Officer, Director
- Robert RosielloDirector
- David WornDirector
- Ponsi TrivisvavetExecutive Officer, Director
- Charles R. CarelliExecutive Officer
- Robert Berendes, Ph.D.Director
- Howard W. BuffettDirector
- Kenneth A. MaceExecutive Officer
- Offering amount
- $40.1M
- Amount sold
- $40.1M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapflagship pioneering11 shared keywordsFlagship Pioneering is a firm that builds and funds companies in life sciences and related fields, describing itself as focused on breakthroughs for people and the planet.
Preqin8 shared keywordsPreqin provides private markets data, analytics, and benchmarking across private equity, venture capital, hedge funds, real estate, private credit, infrastructure, secondaries, and natural resources. Its products serve fund managers, investors, consultants, banks, and other financial professionals for fundraising, manager selection, due diligence, and performance analysis.
Inari Medical8 shared keywordsInari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.
Companies competing with Inari for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frankly Speaking: Why did cash-rich Insas sell Inari for ‘working capital’?theedgemalaysia.com · Jul 2026
WL council finds Inari lacking on tax abatement deal; Rolls-Royce, Saab cleared - AOLaol.com · Jul 2026Frequently asked questions
- What does Inari do?
- Inari applies artificial intelligence and gene editing to accelerate plant breeding, delivering crop improvement solutions for farmers focused on soybeans, corn, and wheat across broadacre agriculture.
- Who are Inari's investors?
- Inari's investors include Flagship Pioneering, Acre Venture Partners, Congruent Ventures, G Squared.
- How much funding has Inari raised?
- Inari has disclosed $335M raised across 3 of its 5 known rounds.
- Where is Inari headquartered?
- Inari is headquartered in Cambridge, US.